The Venture Codex Logo

The Venture Codex

TAO Synergies

1185 Avenue of the Americas, 3rd Floor, New York, 10036, United States

Overview

TAO Synergies is a company that recently completed a Series E financing. On or around October 15, 2025, the company raised $11 million in private capital by issuing 11,000 shares of Series E convertible preferred stock. The company has not publicly detailed its core product or service, but investor demand enabled a sizable late-stage round. The new funding strengthens TAO Synergies’ balance sheet ahead of its next phase of growth. Interest in the broader TAO ecosystem was evident when Bittensor hosted meetups in Shenzhen and Hong Kong on October 25-26, 2025, bringing together TAO token users, builders, and investors anticipating news that could influence TAOBUSD prices. No revenue, user, or other operating metrics were disclosed in the available information.

Total raised
$11M
Funding rounds
1
Latest round
Series E
Latest activity
Oct 2025

Industries

  • Biopharma
  • Biotechnology
  • Pharmaceutical
Visit website

Recent funding

  1. Series E

    Oct 2025

    $11M

Team

  • Alan Tuchman

    Chief Executive Officer

  • Daniel Alkon

    President & Chief Scientific Officer

  • James Altucher

    lead TAO

    LinkedIn
  • Robert Weinstein

    Chief Financial Officer